Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04246463

Terumo Aortic Global Endovascular Registry

A Global Post Market Evaluation of Terumo Aortic Endovascular Grafts

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Vascutek Ltd. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Multi-arm, multi-center, open label, prospective observational registry designed to obtain safety and performance data on the use of CE marked and custom Terumo Aortic endovascular grafts.

Detailed description

Post Market registry collecting real world, post-approval safety, performance, patient reported outcomes and health economic data on patients treated with Terumo Aortic endovascular stent-grafts in standard clinical practice.

Conditions

Interventions

TypeNameDescription
DEVICEThoracicImplant of a Relay stent graft system
DEVICEAbdominalImplant with an Anaconda or Treo Stent graft system
DEVICECustom DeviceImplant of a Fenestrated device such as Fenestrated Anaconda or Fenestrated TREO, Relay Branch or other customised device
DEVICEIlliac ArteryImplant with an Anaconda Iliac leg only

Timeline

Start date
2019-12-17
Primary completion
2029-11-01
Completion
2030-11-01
First posted
2020-01-29
Last updated
2026-03-13

Locations

58 sites across 10 countries: United States, Belgium, France, Germany, Italy, Netherlands, Portugal, Spain, Switzerland, United Kingdom

Source: ClinicalTrials.gov record NCT04246463. Inclusion in this directory is not an endorsement.